About the journal
Case Reports in Oncology is an open-access journal published by Karger Publishers in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,010 CHF. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Karger Publishers
- ISSN
- 1662-6575
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,010 CHF
- Articles in DOAJ
- 2758
- Declared review time
- 11 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.karger.com/cro
Index listings
- DOAJ · 2009-12-14
- PUBMED · 2008-10-17
- Indexing
- DOAJ · PUBMED
- APC
- 1,010 CHF
- Declared review time (DOAJ)
- 11 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2758
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
11weeks
Works in OpenAlex
2780
Last recorded publication year
2026
h-index
38
i10-index
570
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-11-09
- Added to DOAJ
- 2009-12-14
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 36%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101517601
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cardiac tumors and thrombi
- Lymphoma Diagnosis and Treatment
- Cardiac tumors and thrombi
- Lymphoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Metastasis and carcinoma case studies
- Brain Metastases and Treatment
- Metastasis and carcinoma case studies
- Brain Metastases and Treatment
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Vascular Tumors and Angiosarcomas
- Vascular Tumors and Angiosarcomas
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Cancer and Skin Lesions
- Cancer and Skin Lesions
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Salivary Gland Tumors Diagnosis and Treatment
- Salivary Gland Tumors Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Acute Myeloid Leukemia Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Acute Myeloid Leukemia Research
Keywords (DOAJ)
- cancer
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ